Related Experiment Videos
Juvenile form of dihydropteridine reductase deficiency in 2 Tunisian patients
A Larnaout1, S Belal, N Miladi
1Service de Neurologie, National Institute of Neurology, Tunis, Tunisia.
Neuropediatrics
|February 24, 1999
Insights
Juvenile-onset dihydropteridine reductase (DHPR) deficiency caused progressive encephalopathy in two brothers. Symptoms included intellectual disability, epilepsy, and motor deficits starting around age six.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Dihydropteridine reductase (DHPR) is crucial for neurotransmitter synthesis.
- DHPR deficiency is a rare genetic disorder affecting the folate pathway.
- Early diagnosis and treatment are vital for managing neurological symptoms.
Observation:
- Two brothers presented with normal development until age six.
- They subsequently developed a fluctuating and progressive encephalopathy.
- Clinical manifestations included intellectual disability, epilepsy, and motor abnormalities.
Findings:
- The brothers were diagnosed with juvenile-onset DHPR deficiency.
- This genetic disorder led to severe neurological impairment.
- The progressive nature of the disease highlights the importance of enzyme function.
Implications:
- Understanding DHPR deficiency is key for early intervention strategies.
- This case highlights the neurological impact of metabolic disorders.
- Further research into DHPR pathways could reveal new therapeutic targets.
Abstract:
Two brothers are described who had juvenile-onset DHPR deficiency. Both were considered normal until six years of age when they developed a fluctuating and progressive encephalopathy combining mental retardation, epilepsy, pyramidal, cerebellar and extrapyramidal signs.